Possible approaches in precision medicine for secundary CV prevention
CSI Rome Nicole Jaspers en Gijs Berkelmans (both UMC Utrecht, The Netherlands) discuss the role of precision medicine in secondary prevention with Dr. Noel Bairey Merz (Los Angeles, CA, USA), as well as which approaches and types of data can be considered to assess risk.
Video navigation menu
- Proteomic analyses as an approach in precision medicine 0:25
- Patient-reported outcomes to monitor severity of angina and measuring activity 1:54
- Combining all datasources to predict MACE in individuals at moderate risk 2:40
- The individual proteome might predict CVD risk 3:32
In the Cardiovascular Scene Investigation (CSI) series, young clinicians with an investigative mindset interview experts about the context and meaning of the results they just presented at the ESC congress.
The series is aimed to explore the background and practical implications of recent scientific developments, like those discussed in the Advances in Science session on Improving cardiovascular disease prevention at the ESC Congress 2016, with speakers in this session.
Noel Bairey Merz - Director of Preventive and Rehabilitative Cardiac Center, Director of Clinical Scholars Program, Medical Director of Women's Heart Center, Professor of Medicine at Cedars-Sinai Medical Center, Los Angeles, CA, USA
Nicole Jaspers and Gijs Berkelmans - UMC Utrecht, The Netherlands
The speakers did not receive financial compensation for participating in these interviews